secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARTELO BIOSCIENCES, INC. (ARTL)
CIK:        0001621221
Form:       8-K
Filed at:   2026-02-05T23:59:59+00:00
Accession:  0001640334-26-000227
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Artelo enters up to $50M equity purchase facility with Square Gate; issues 292K commitment shares
--------------------------------------------------------------------------------

- Equity Purchase Agreement with Square Gate provides up to $25M initially, expandable to $50M at company's option.
- Company issued 292,398 commitment shares valued at $500,000 to Square Gate as consideration.
- Purchase price set at 95% of lowest VWAP during valuation period (Regular Put) or lowest traded price (Intraday Put).
- Regular Put capped at $500K or 30% of daily volume; Intraday Put limited to 4.99% of outstanding shares.
- Registration statement must be filed within 30 days; facility runs until Jan 2029 or earlier termination.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1621221/000164033426000227/0001640334-26-000227-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1621221/000164033426000227/artl_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-26-000227

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer